148 results on '"Chernobrovkin, Alexey"'
Search Results
2. CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target
3. Expression proteomics reveals protein targets and highlights mechanisms of action of small molecule drugs
4. System-wide identification and prioritization of enzyme substrates by thermal analysis
5. Anticancer Effect of Deuterium Depleted Water - Redox Disbalance Leads to Oxidative Stress
6. Comparative Proteomics of Dying and Surviving Cancer Cells Improves the Identification of Drug Targets and Sheds Light on Cell Life/Death Decisions
7. DAF-16/FOXO requires Protein Phosphatase 4 to initiate transcription of stress resistance and longevity promoting genes
8. Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology
9. ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
10. Abstract 5987: Differential targets engaged by narazaciclib in comparison to the approved CDK4/6 inhibitors contribute to enhanced inhibition of tumor cell growth
11. Methionine to isothreonine conversion as a source of false discovery identifications of genetically encoded variants in proteogenomics
12. DeMix Workflow for Efficient Identification of Cofragmented Peptides in High Resolution Data-dependent Tandem Mass Spectrometry
13. Proteomics-Compatible Fourier Transform Isotopic Ratio Mass Spectrometry of Polypeptides
14. Protein domain-dependent vesiculation of Lipoprotein A, a protein that is important in cell wall synthesis and fitness of the human respiratory pathogen Haemophilus influenzae
15. Haptoglobin Induces a Specific Proteomic Profile and a Mature-Associated Phenotype on Primary Human Monocyte-Derived Dendritic Cells
16. Abstract 2924: Target identification, selectivity profiling and mechanistic insights of a Cdk9 inhibitor using complementary proteomics methods
17. Narazaciclib’s kinase inhibitory activity is differentiated from approved CDK4/6 inhibitors in preclinical models.
18. Abnormal (Hydroxy)proline Deuterium Content Redefines Hydrogen Chemical Mass
19. Protein domain-dependent vesiculation of Lipoprotein A, a protein that is important in cell wall synthesis and fitness of the human respiratory pathogen Haemophilus influenzae
20. A mass spectrometry‐based non‐radioactive differential radial capillary action of ligand assay (DRaCALA) to assess ligand binding to proteins
21. Abnormal (Hydroxy)proline Deuterium Content Redefines Hydrogen Chemical Mass
22. Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics Methods
23. Abnormal (hydroxy)prolines deuterium content redefines hydrogen chemical mass
24. A non-radioactive mass spectrometry based differential radial capillary action of ligand assay (DRaCALA) to assess ligand binding to proteins
25. sj-pdf-1-jbx-10.1177_2472555220984372 – Supplemental material for A Tale of Two Tails: Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts
26. SIESTA as a universal unbiased proteomics approach for identification and prioritization of enzyme substrates
27. Chromosome-centric approach to overcoming bottlenecks in the Human Proteome Project
28. Histone Purification Combined with High‐Resolution Mass Spectrometry to Examine Histone Post‐Translational Modifications and Histone Variants in Caenorhabditis elegans
29. A tale of two tails - efficient profiling of protein degraders by specific functional and target engagement readouts
30. A Cyclic di-GMP Network Is Present in Gram-Positive Streptococcus and Gram-Negative Proteus Species
31. CETSA® MS profiling for a comparative assessment of FDA approved antivirals repurposed for COVID-19 therapy identifies Trip13 as a Remdesivir off-target
32. In-depth characterization of Staurosporine induced proteome thermal stability changes
33. Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics Methods.
34. A Cyclic di-GMP Network Is Present in Gram-Positive Streptococcus and Gram-Negative Proteus Species.
35. Proteogenomics of Adenosine-to-Inosine RNA Editing in the Fruit Fly
36. System-wide identification and prioritization of enzyme substrates by thermal analysis (SIESTA)
37. ProTargetMiner: A proteome signature library of anticancer molecules for functional discovery
38. Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy
39. Expression proteomics study to determine metallodrug targets and optimal drug combinations
40. Proteomic analysis of heat-conditioned cancer cell lysates used for anti-melanoma DC-based immunotherapy
41. Proteogenomics of adenosine-to-inosine RNA editing in the fruit fly
42. Cytotoxic and Proinflammatory Effects of Metal-Based Nanoparticles on THP-1 Monocytes Characterized by Combined Proteomics Approaches
43. How well can morphology assess cell death modality? A proteomics study
44. Proteogenomics of Malignant Melanoma Cell Lines: The Effect of Stringency of Exome Data Filtering on Variant Peptide Identification in Shotgun Proteomics.
45. Functional Identification of Target by Expression Proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs
46. Functional Identification of Target by Expression Proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs
47. Cytotoxic and Proinflammatory Effects of Metal-Based Nanoparticles on THP-1 Monocytes Characterized by Combined Proteomics Approaches.
48. Exome-Driven Characterization of the Cancer Cell Lines at the Proteome Level: The NCI-60 Case Study
49. Detection of Viral Proteins in Human Cells Lines by Xeno-Proteomics: Elimination of the Last Valid Excuse for Not Testing Every Cellular Proteome Dataset for Viral Proteins
50. Comparative Ranking of Human Chromosomes Based on Post-Genomic Data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.